RI S2122 | 2020 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 22 2020 - 25% progression, died in committee
Action: 2020-02-25 - Committee recommended measure be held for further study
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 22 2020 - 25% progression, died in committee
Action: 2020-02-25 - Committee recommended measure be held for further study
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.
Title
Prescription Drug Sales -- Representative Disclosure Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2020-02-25 | Senate | Committee recommended measure be held for further study |
| 2020-02-21 | Senate | Scheduled for hearing and/or consideration (02/25/2020) |
| 2020-01-22 | Senate | Introduced, referred to Senate Health and Human Services |
Rhode Island State Sources
| Type | Source |
|---|---|
| Summary | https://status.rilegislature.gov/ |
| Text | https://webserver.rilegislature.gov/BillText20/SenateText20/S2122.pdf |
